Lasagna, A.; Cassaniti, I.; Arena, F.; Bergami, F.; Percivalle, E.; Comolli, G.; Sarasini, A.; Ferrari, A.; Cicognini, D.; Schiavo, R.;
et al. Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up. Int. J. Mol. Sci. 2023, 24, 6731.
https://doi.org/10.3390/ijms24076731
AMA Style
Lasagna A, Cassaniti I, Arena F, Bergami F, Percivalle E, Comolli G, Sarasini A, Ferrari A, Cicognini D, Schiavo R,
et al. Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up. International Journal of Molecular Sciences. 2023; 24(7):6731.
https://doi.org/10.3390/ijms24076731
Chicago/Turabian Style
Lasagna, Angioletta, Irene Cassaniti, Francesca Arena, Federica Bergami, Elena Percivalle, Giuditta Comolli, Antonella Sarasini, Alessandro Ferrari, Daniela Cicognini, Roberta Schiavo,
and et al. 2023. "Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up" International Journal of Molecular Sciences 24, no. 7: 6731.
https://doi.org/10.3390/ijms24076731
APA Style
Lasagna, A., Cassaniti, I., Arena, F., Bergami, F., Percivalle, E., Comolli, G., Sarasini, A., Ferrari, A., Cicognini, D., Schiavo, R., Lo Cascio, G., Pedrazzoli, P., & Baldanti, F.
(2023). Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up. International Journal of Molecular Sciences, 24(7), 6731.
https://doi.org/10.3390/ijms24076731
